Gemcitabine prodrug (Helix BioPharma)

吉西他滨前药 (Helix BioPharma)

Report date: 2026/03/30 17:02:26

Base Information

Drug NameGemcitabine prodrug (Helix BioPharma)
Drug Alias NameGEMCEDALR-06LR-06B
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionRibonucleotide reductase inhibitorsDNA inhibitors
TargetsRibonucleotide reductaseDNA
Therapy Area/IndicationsOvarian NeoplasmsPancreatic NeoplasmsBreast Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLaevoroc Oncology AG
China Registration ClassN/A

Develop Information

Active CompaniesHelix Biopharma Corp
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsPancreatic NeoplasmsBreast Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A